Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs
about
Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling TechniquesA systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problemsDoes the Strategy of Risk Group Testing for Hepatitis C Hit the Target?Clinical impact of treatment timing for chronic hepatitis C infection: a decision modelSpillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients.Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs.The cost-effectiveness of treating triple coinfection with HIV, tuberculosis and hepatitis C virus.The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.HCV Health Policy Developments in Response to the National Viral Hepatitis Action Plan: A Brief Update.Economic evaluation of HCV testing approaches in low and middle income countries.The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013.Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs.
P2860
Q26774500-0561AC4F-7F16-48C1-8B6F-6B30D7F470C1Q28072735-4E59A010-BB45-404A-A8DF-EBDBB8E58279Q33858322-031E66DF-A8C2-4DC3-88E0-7C9D56A5B779Q35889164-50A1A76E-63C9-4AB9-8E8D-9F223E276AFFQ36090286-DA1742B2-F970-4FA4-8834-A5C145F9571AQ36260469-C574F365-98B1-45FC-8F6F-5EEC1D44D28AQ36903236-869C8FA7-2CB8-472F-A204-002CC8B30F6FQ40711194-30C0AE87-505D-4D36-A85C-743ED545544AQ41919051-BBBDD363-6C2A-481D-9790-CA597279F669Q42048758-5395C131-44BE-40DE-8B34-FA81A7223C36Q42050428-249B9A9B-CA3B-4ECA-9573-E2B962EBEFBDQ46983780-2D7F6B37-8349-4142-9F0F-3B0E8C6788CFQ47801305-F4993E42-C3B3-458A-ABCF-ABCBE49C8DD1Q48506117-AE762498-EFD2-4018-B793-8AEEF219FB9BQ52686909-AC85A312-1E16-44DB-86A5-784108BDAAAD
P2860
Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cost-effectiveness of rapid he ...... tance abuse treatment programs
@ast
Cost-effectiveness of rapid he ...... tance abuse treatment programs
@en
Cost-effectiveness of rapid hepatitis C virus
@nl
type
label
Cost-effectiveness of rapid he ...... tance abuse treatment programs
@ast
Cost-effectiveness of rapid he ...... tance abuse treatment programs
@en
Cost-effectiveness of rapid hepatitis C virus
@nl
prefLabel
Cost-effectiveness of rapid he ...... tance abuse treatment programs
@ast
Cost-effectiveness of rapid he ...... tance abuse treatment programs
@en
Cost-effectiveness of rapid hepatitis C virus
@nl
P2093
P2860
P50
P356
P1433
P1476
Cost-effectiveness of rapid he ...... tance abuse treatment programs
@en
P2093
Benjamin P Linas
Bruce R Schackman
Daniel J Feaster
Devra M Barter
Lisa R Metsch
Madeline A DiLorenzo
P2860
P304
P356
10.1111/ADD.12754
P407
P577
2015-01-01T00:00:00Z